---
title: "GT Biopharma (GTBP.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GTBP.US/norm.md"
symbol: "GTBP.US"
name: "GT Biopharma"
parent: "https://longbridge.com/en/quote/GTBP.US.md"
datetime: "2026-05-20T22:22:51.936Z"
locales:
  - [en](https://longbridge.com/en/quote/GTBP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GTBP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GTBP.US/norm.md)
---

# GT Biopharma (GTBP.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1113 | -2.23 | -0.8268 | -0.5477 | -0.3309 |
| ROE | -201.66% | -2631.49% | -444.85% | -646.30% | 234.09% |
| Revenue | - | - | - | - | - |
| Net income | -3.37M | -28.90M | -3.26M | -1.52M | -776000.00 |
| Operating income | -2.85M | -5.59M | -3.38M | -1.51M | -1.93M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 10.00M | 8.11M | 4.32M | 7.12M | 2.66M |
| Leverage | 1.32 | 1.40 | 1.44 | 1.48 | -2.71 |
| BVPS | 0.2154 | 0.2266 | 0.4955 | 0.8738 | -0.3868 |
| Turnover | - | - | - | - | - |
| Cash & STI | 8.92M | 6.81M | 2.53M | 5.23M | 2.37M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -8.92M | -6.81M | -2.53M | -5.23M | -2.37M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.47M | -4.02M | -3.68M | -3.01M | -2.20M |
| Investing CF | - | - | - | - | - |
| Financing CF | 4.58M | 8.30M | 977000.00 | 5.88M | 616000.00 |
| Free CF | -1.46M | -1.95M | -2.62M | -3.88M | -3.48M |
| OCF coverage | - | -2792.36% | -4325.88% | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |